3,4-annelated benzimidazol-2-(1H)-one 1-carboxylic acid derivati

Details 3,4-annelated benzimidazol-2-(1H)-one 1-carboxylic acid derivati 3,4-annelated benzimidazol-2-(1H)-one 1-carboxylic acid derivati

1992-09-28

1994-07-05

Cintins, Marianne M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

546 84, C07D47104, A61K 3147

Patent

active

053267680

ABSTRACT:
The present invention concerns 3,4-annelated benzimidazol-2(1H)-one 1-carboxylic acid derivatives of the formula ##STR1## wherein R.sub.0, Z, A, B and C are as defined herein. Such derivatives are useful in the treatment of symptoms which are caused by over-excitation of 5-hydroxytryptamine receptors.

REFERENCES:
patent: 2320439 (1943-06-01), Kumetat et al.
patent: 4313950 (1982-02-01), Guzzi et al.
patent: 4950759 (1990-08-01), van Wijngaarden et al.
patent: 4985420 (1991-01-01), Hamminga et al.
patent: 4985424 (1991-01-01), van Wijingaarden et al.
Chemical Abstracts 74 53657d (1971).

Affiliated with

Also associated with

Rating

3,4-annelated benzimidazol-2-(1H)-one 1-carboxylic acid derivati does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3,4-annelated benzimidazol-2-(1H)-one 1-carboxylic acid derivati, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3,4-annelated benzimidazol-2-(1H)-one 1-carboxylic acid derivati will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-796144